Drug Trial Radar · NCT00293319
131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Last checked: Nov 20, 2026Latest source record: Aug 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
164
Actual
Start
Apr 2005
Primary completion
Mar 2006
Study completion Mar 2006
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Feb 17, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Radioactive drugs, such as 131 I-MIBG, may carry radiation directly to tumor cells and not harm normal cells. PURPOSE: This phase II trial is studying how well 131 I-MIBG works in treating patients with refractory or relapsed neuroblastoma.
Conditions
- Neuroblastoma
Interventions
filgrastimBiological
iobenguane I 131Radiation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ability of iodine I 131 metaiodobenzylguanidine to provide palliative therapy
- Acute and late toxicities
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
UCSF Comprehensive Cancer Center
San Francisco, California
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.